Clinical Trial Update: Suramin in Treating Patients With Recurrent Primary Brain Tumors [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update reports the completion of a Phase 2 study evaluating suramin in patients with recurrent primary brain tumors. The sponsor is Emor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors

Drugs mentioned

• Suramin (suramin)

Snippet

Sponsor: Emory University | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED